Genzyme Vet McGorry Steps in as New CEO of Harvard Apparatus

Xconomy Boston — 

James McGorry, a 12-year veteran of Genzyme, has been named the new CEO of Holliston, MA-based Harvard Apparatus Regenerative Technology (NASDAQ: HART). HART has been searching for a new CEO since founding executive David Green resigned in April, saying in a statement that “the time was right to bring in a new CEO who has experience in guiding a biotechnology company through clinical trials and product launches.” HART is developing replacement organs that incorporate a patient’s own cells.